Quest Diagnostics Incorporated (DGX) earnings
DGX earnings moved a median of +0.25% by the close. Quarterly and annual DGX reports and results, each read against the price at its own news timestamp. Back to the DGX overview →
27 measured DGX earnings events.
Where these DGX earnings landedvs 27 measured DGX earnings reactions
| Middle 50% of DGX earnings reactions | -0.54% to +1.20% |
|---|---|
| Median reaction (to close) | +0.25% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 DGX earnings events with a measured close landed between -0.54% and +1.20%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q QUEST DIAGNOSTICS INC For: Jun 30 | SEC filing · Form 10-Q | -2.01% | -0.06% | |
| Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 | Press release | +4.08% | +1.29% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Mar 31 | SEC filing · Form 10-Q | -0.14% | -2.80% | |
| Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 | Press release | +0.00% | -0.22% | |
| Form 10-K QUEST DIAGNOSTICS INC For: Dec 31 | SEC filing · Form 10-K | -0.09% | +0.39% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Sep 30 | SEC filing · Form 10-Q | -1.99% | -6.16% | |
| Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 | Press release | -1.99% | -6.16% | |
| Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 | Press release | -0.04% | -0.71% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Jun 30 | SEC filing · Form 10-Q | +0.56% | -0.36% | |
| Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 | Press release | +0.40% | +4.16% | |
| Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 | Press release | +0.06% | +0.26% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Mar 31 | SEC filing · Form 10-Q | -0.28% | +1.14% | |
| Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 | Press release | +0.97% | +1.95% | |
| Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 | Press release | -0.67% | -1.20% | |
| Form 10-K QUEST DIAGNOSTICS INC For: Dec 31 | SEC filing · Form 10-K | +0.29% | +0.57% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Sep 30 | SEC filing · Form 10-Q | -0.09% | +0.25% | |
| Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 | Press release | -0.64% | +1.46% | |
| Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 | Press release | +0.11% | -0.08% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Jun 30 | SEC filing · Form 10-Q | +0.59% | -0.28% | |
| Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 | Press release | -0.54% | -2.08% | |
| Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024 | Press release | -0.21% | +1.34% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Mar 31 | SEC filing · Form 10-Q | +0.17% | -1.55% | |
| Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 | Press release | +1.70% | +1.26% | |
| Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024 | Press release | +0.08% | +0.14% | |
| Form 10-K QUEST DIAGNOSTICS INC For: Dec 31 | SEC filing · Form 10-K | -0.16% | +1.07% | |
| Form 10-Q QUEST DIAGNOSTICS INC For: Sep 30 | SEC filing · Form 10-Q | +0.42% | +4.75% | |
| Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 | Press release | +0.46% | +0.75% |
Keep exploring
More DGX: analyst actions → · SEC filings → · DGX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Dr. Reddy's Laboratories Ltd (RDY) | 528 | 0.00% | 47% |
| LOXO ONCOLOGY (LOXO) | 526 | 0.00% | 49% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 524 | -0.32% | 46% |
| STAAR Surgical Company (STAA) | 522 | -0.21% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.